Arcturus Therapeutics Holdings Inc.
ARCT
$18.51
$1.035.89%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.78% | 53.09% | -334.67% | 59.90% | 35.80% |
| Total Depreciation and Amortization | -2.75% | -2.20% | -10.20% | 0.33% | 0.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.31% | -24.15% | -9.12% | -1.19% | -3.24% |
| Change in Net Operating Assets | 87.10% | -242.08% | 173.14% | -16.16% | -331.49% |
| Cash from Operations | 83.62% | -12,272.54% | 98.80% | 21.16% | -442.41% |
| Capital Expenditure | 100.00% | -- | 100.00% | 75.61% | -36.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | 100.00% | 75.61% | -36.67% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 40.51% | 45.52% | -80.66% | -71.16% | 9.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -196.91% | 11,239.55% | -80.66% | -71.16% | 9.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.00% | -13,286.67% | 99.35% | 17.52% | -677.69% |